Document is current
Any future updates will be listed below
-
Authors
Ahmad, Haroon
Schiff, David
- License Information
-
More Information
Article History
First Online: 9 May 2019
Compliance with Ethical Standards
:
: Haroon Ahmad declares that he has no conflict of interest.David Schiff previously served as site PI for a trial (funded by Genentech) of bevacizumab in recurrent meningioma. His institution received per-subject payment for trial accrual.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
